Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:sepimostat'
(id=7121224 ; fe=en:sepimostat ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2430 creation date=2017-06-25 touchdate=2025-07-24 23:14:50.000)
≈ 84 relations sortantes

  1. en:sepimostat -- r_associated #0: 43 / 1 -> en:cilastatin sodium
    n1=en:sepimostat | n2=en:cilastatin sodium | rel=r_associated | relid=0 | w=43
  2. en:sepimostat -- r_associated #0: 43 / 1 -> en:tosedostat
    n1=en:sepimostat | n2=en:tosedostat | rel=r_associated | relid=0 | w=43
  3. en:sepimostat -- r_associated #0: 41 / 0.953 -> en:fasidotril
    n1=en:sepimostat | n2=en:fasidotril | rel=r_associated | relid=0 | w=41
  4. en:sepimostat -- r_associated #0: 39 / 0.907 -> en:angiotensin-converting enzyme inhibitors
    n1=en:sepimostat | n2=en:angiotensin-converting enzyme inhibitors | rel=r_associated | relid=0 | w=39
  5. en:sepimostat -- r_associated #0: 39 / 0.907 -> en:ecabet
    n1=en:sepimostat | n2=en:ecabet | rel=r_associated | relid=0 | w=39
  6. en:sepimostat -- r_associated #0: 38 / 0.884 -> en:daglutril
    n1=en:sepimostat | n2=en:daglutril | rel=r_associated | relid=0 | w=38
  7. en:sepimostat -- r_associated #0: 37 / 0.86 -> en:lopinavir
    n1=en:sepimostat | n2=en:lopinavir | rel=r_associated | relid=0 | w=37
  8. en:sepimostat -- r_associated #0: 36 / 0.837 -> en:aleplasinin
    n1=en:sepimostat | n2=en:aleplasinin | rel=r_associated | relid=0 | w=36
  9. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:avagacestat
    n1=en:sepimostat | n2=en:avagacestat | rel=r_associated | relid=0 | w=35
  10. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:ciluprevir
    n1=en:sepimostat | n2=en:ciluprevir | rel=r_associated | relid=0 | w=35
  11. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:gemopatrilat
    n1=en:sepimostat | n2=en:gemopatrilat | rel=r_associated | relid=0 | w=35
  12. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:indinavir
    n1=en:sepimostat | n2=en:indinavir | rel=r_associated | relid=0 | w=35
  13. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:odanacatib
    n1=en:sepimostat | n2=en:odanacatib | rel=r_associated | relid=0 | w=35
  14. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:paritaprevir
    n1=en:sepimostat | n2=en:paritaprevir | rel=r_associated | relid=0 | w=35
  15. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:patamostat
    n1=en:sepimostat | n2=en:patamostat | rel=r_associated | relid=0 | w=35
  16. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:racecadotril
    n1=en:sepimostat | n2=en:racecadotril | rel=r_associated | relid=0 | w=35
  17. en:sepimostat -- r_associated #0: 35 / 0.814 -> en:sivelestat
    n1=en:sepimostat | n2=en:sivelestat | rel=r_associated | relid=0 | w=35
  18. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:amprenavir
    n1=en:sepimostat | n2=en:amprenavir | rel=r_associated | relid=0 | w=34
  19. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:batebulast
    n1=en:sepimostat | n2=en:batebulast | rel=r_associated | relid=0 | w=34
  20. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:c1 esterase inhibitor (recombinant)
    n1=en:sepimostat | n2=en:c1 esterase inhibitor (recombinant) | rel=r_associated | relid=0 | w=34
  21. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:camostat mesylate
    n1=en:sepimostat | n2=en:camostat mesylate | rel=r_associated | relid=0 | w=34
  22. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:cystamine dihydrochloride
    n1=en:sepimostat | n2=en:cystamine dihydrochloride | rel=r_associated | relid=0 | w=34
  23. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:dipeptidyl-peptidase iv inhibitors
    n1=en:sepimostat | n2=en:dipeptidyl-peptidase iv inhibitors | rel=r_associated | relid=0 | w=34
  24. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:efegatran
    n1=en:sepimostat | n2=en:efegatran | rel=r_associated | relid=0 | w=34
  25. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:fda established names and unique ingredient identifier codes terminology
    n1=en:sepimostat | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=34
  26. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:flurofamide
    n1=en:sepimostat | n2=en:flurofamide | rel=r_associated | relid=0 | w=34
  27. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:ns5b polymerase inhibitor bms-791325
    n1=en:sepimostat | n2=en:ns5b polymerase inhibitor bms-791325 | rel=r_associated | relid=0 | w=34
  28. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:o-chloroacetylcarbamoylfumagillol
    n1=en:sepimostat | n2=en:o-chloroacetylcarbamoylfumagillol | rel=r_associated | relid=0 | w=34
  29. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:proteinase inhibitor (substance)
    n1=en:sepimostat | n2=en:proteinase inhibitor (substance) | rel=r_associated | relid=0 | w=34
  30. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:saquinavir
    n1=en:sepimostat | n2=en:saquinavir | rel=r_associated | relid=0 | w=34
  31. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:serine proteinase inhibitors
    n1=en:sepimostat | n2=en:serine proteinase inhibitors | rel=r_associated | relid=0 | w=34
  32. en:sepimostat -- r_associated #0: 34 / 0.791 -> en:tissue inhibitor of metalloproteinases
    n1=en:sepimostat | n2=en:tissue inhibitor of metalloproteinases | rel=r_associated | relid=0 | w=34
  33. en:sepimostat -- r_associated #0: 32 / 0.744 -> en:candoxatrilat
    n1=en:sepimostat | n2=en:candoxatrilat | rel=r_associated | relid=0 | w=32
  34. en:sepimostat -- r_associated #0: 32 / 0.744 -> en:dexecadotril
    n1=en:sepimostat | n2=en:dexecadotril | rel=r_associated | relid=0 | w=32
  35. en:sepimostat -- r_associated #0: 32 / 0.744 -> en:elastase inhibitor
    n1=en:sepimostat | n2=en:elastase inhibitor | rel=r_associated | relid=0 | w=32
  36. en:sepimostat -- r_associated #0: 32 / 0.744 -> en:proteasome inhibitor
    n1=en:sepimostat | n2=en:proteasome inhibitor | rel=r_associated | relid=0 | w=32
  37. en:sepimostat -- r_associated #0: 32 / 0.744 -> en:remikiren
    n1=en:sepimostat | n2=en:remikiren | rel=r_associated | relid=0 | w=32
  38. en:sepimostat -- r_associated #0: 32 / 0.744 -> en:rupintrivir
    n1=en:sepimostat | n2=en:rupintrivir | rel=r_associated | relid=0 | w=32
  39. en:sepimostat -- r_associated #0: 31 / 0.721 -> en:darunavir
    n1=en:sepimostat | n2=en:darunavir | rel=r_associated | relid=0 | w=31
  40. en:sepimostat -- r_associated #0: 31 / 0.721 -> en:darunavir ethanolate
    n1=en:sepimostat | n2=en:darunavir ethanolate | rel=r_associated | relid=0 | w=31
  41. en:sepimostat -- r_associated #0: 31 / 0.721 -> en:ritonavir
    n1=en:sepimostat | n2=en:ritonavir | rel=r_associated | relid=0 | w=31
  42. en:sepimostat -- r_associated #0: 31 / 0.721 -> en:trypsin inhibitors
    n1=en:sepimostat | n2=en:trypsin inhibitors | rel=r_associated | relid=0 | w=31
  43. en:sepimostat -- r_associated #0: 30 / 0.698 -> en:aderbasib
    n1=en:sepimostat | n2=en:aderbasib | rel=r_associated | relid=0 | w=30
  44. en:sepimostat -- r_associated #0: 30 / 0.698 -> en:begacestat
    n1=en:sepimostat | n2=en:begacestat | rel=r_associated | relid=0 | w=30
  45. en:sepimostat -- r_associated #0: 30 / 0.698 -> en:bowman-birk inhibitor concentrate
    n1=en:sepimostat | n2=en:bowman-birk inhibitor concentrate | rel=r_associated | relid=0 | w=30
  46. en:sepimostat -- r_associated #0: 30 / 0.698 -> en:ecadotril
    n1=en:sepimostat | n2=en:ecadotril | rel=r_associated | relid=0 | w=30
  47. en:sepimostat -- r_associated #0: 30 / 0.698 -> en:relacatib
    n1=en:sepimostat | n2=en:relacatib | rel=r_associated | relid=0 | w=30
  48. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:acluracil
    n1=en:sepimostat | n2=en:acluracil | rel=r_associated | relid=0 | w=29
  49. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:chymotrypsin inhibitor
    n1=en:sepimostat | n2=en:chymotrypsin inhibitor | rel=r_associated | relid=0 | w=29
  50. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:ecallantide
    n1=en:sepimostat | n2=en:ecallantide | rel=r_associated | relid=0 | w=29
  51. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:matrix metalloproteinase inhibitor
    n1=en:sepimostat | n2=en:matrix metalloproteinase inhibitor | rel=r_associated | relid=0 | w=29
  52. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:omapatrilat
    n1=en:sepimostat | n2=en:omapatrilat | rel=r_associated | relid=0 | w=29
  53. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:serine protease inhibitor wx-671
    n1=en:sepimostat | n2=en:serine protease inhibitor wx-671 | rel=r_associated | relid=0 | w=29
  54. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:simeprevir
    n1=en:sepimostat | n2=en:simeprevir | rel=r_associated | relid=0 | w=29
  55. en:sepimostat -- r_associated #0: 29 / 0.674 -> en:telaprevir
    n1=en:sepimostat | n2=en:telaprevir | rel=r_associated | relid=0 | w=29
  56. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:aprotinin
    n1=en:sepimostat | n2=en:aprotinin | rel=r_associated | relid=0 | w=28
  57. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:asunaprevir
    n1=en:sepimostat | n2=en:asunaprevir | rel=r_associated | relid=0 | w=28
  58. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:kni-272
    n1=en:sepimostat | n2=en:kni-272 | rel=r_associated | relid=0 | w=28
  59. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:lexiva
    n1=en:sepimostat | n2=en:lexiva | rel=r_associated | relid=0 | w=28
  60. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:nafamostat mesylate
    n1=en:sepimostat | n2=en:nafamostat mesylate | rel=r_associated | relid=0 | w=28
  61. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:nelfinavir
    n1=en:sepimostat | n2=en:nelfinavir | rel=r_associated | relid=0 | w=28
  62. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:sivelestat sodium
    n1=en:sepimostat | n2=en:sivelestat sodium | rel=r_associated | relid=0 | w=28
  63. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:talabostat mesylate
    n1=en:sepimostat | n2=en:talabostat mesylate | rel=r_associated | relid=0 | w=28
  64. en:sepimostat -- r_associated #0: 28 / 0.651 -> en:urinastatin
    n1=en:sepimostat | n2=en:urinastatin | rel=r_associated | relid=0 | w=28
  65. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:aloxistatin
    n1=en:sepimostat | n2=en:aloxistatin | rel=r_associated | relid=0 | w=27
  66. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:alvelestat
    n1=en:sepimostat | n2=en:alvelestat | rel=r_associated | relid=0 | w=27
  67. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:cysteine proteinase inhibitors
    n1=en:sepimostat | n2=en:cysteine proteinase inhibitors | rel=r_associated | relid=0 | w=27
  68. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:fosamprenavir sodium
    n1=en:sepimostat | n2=en:fosamprenavir sodium | rel=r_associated | relid=0 | w=27
  69. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:freselestat
    n1=en:sepimostat | n2=en:freselestat | rel=r_associated | relid=0 | w=27
  70. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:lodelaben
    n1=en:sepimostat | n2=en:lodelaben | rel=r_associated | relid=0 | w=27
  71. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:nafamostat
    n1=en:sepimostat | n2=en:nafamostat | rel=r_associated | relid=0 | w=27
  72. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:pepstatin
    n1=en:sepimostat | n2=en:pepstatin | rel=r_associated | relid=0 | w=27
  73. en:sepimostat -- r_associated #0: 27 / 0.628 -> en:semagacestat
    n1=en:sepimostat | n2=en:semagacestat | rel=r_associated | relid=0 | w=27
  74. en:sepimostat -- r_associated #0: 26 / 0.605 -> en:camostat
    n1=en:sepimostat | n2=en:camostat | rel=r_associated | relid=0 | w=26
  75. en:sepimostat -- r_associated #0: 26 / 0.605 -> en:cilastatin
    n1=en:sepimostat | n2=en:cilastatin | rel=r_associated | relid=0 | w=26
  76. en:sepimostat -- r_associated #0: 26 / 0.605 -> en:cystamine
    n1=en:sepimostat | n2=en:cystamine | rel=r_associated | relid=0 | w=26
  77. en:sepimostat -- r_associated #0: 26 / 0.605 -> en:depelestat
    n1=en:sepimostat | n2=en:depelestat | rel=r_associated | relid=0 | w=26
  78. en:sepimostat -- r_associated #0: 26 / 0.605 -> en:gabexate
    n1=en:sepimostat | n2=en:gabexate | rel=r_associated | relid=0 | w=26
  79. en:sepimostat -- r_associated #0: 26 / 0.605 -> en:hiv protease inhibitors
    n1=en:sepimostat | n2=en:hiv protease inhibitors | rel=r_associated | relid=0 | w=26
  80. en:sepimostat -- r_associated #0: 26 / 0.605 -> en:talabostat
    n1=en:sepimostat | n2=en:talabostat | rel=r_associated | relid=0 | w=26
  81. en:sepimostat -- r_associated #0: 20 / 0.465 -> amprénavir
    n1=en:sepimostat | n2=amprénavir | rel=r_associated | relid=0 | w=20
  82. en:sepimostat -- r_associated #0: 20 / 0.465 -> en:hiv protease inhibitor
    n1=en:sepimostat | n2=en:hiv protease inhibitor | rel=r_associated | relid=0 | w=20
  83. en:sepimostat -- r_associated #0: 20 / 0.465 -> nelfinavir
    n1=en:sepimostat | n2=nelfinavir | rel=r_associated | relid=0 | w=20
  84. en:sepimostat -- r_associated #0: 1 / 0.023 -> en:organic chemical
    n1=en:sepimostat | n2=en:organic chemical | rel=r_associated | relid=0 | w=1
≈ 91 relations entrantes

  1. en:nelfinavir --- r_associated #0: 47 --> en:sepimostat
    n1=en:nelfinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=47
  2. nelfinavir --- r_associated #0: 46 --> en:sepimostat
    n1=nelfinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=46
  3. en:ecabet --- r_associated #0: 43 --> en:sepimostat
    n1=en:ecabet | n2=en:sepimostat | rel=r_associated | relid=0 | w=43
  4. en:odanacatib --- r_associated #0: 37 --> en:sepimostat
    n1=en:odanacatib | n2=en:sepimostat | rel=r_associated | relid=0 | w=37
  5. amprénavir --- r_associated #0: 36 --> en:sepimostat
    n1=amprénavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=36
  6. en:dexecadotril --- r_associated #0: 35 --> en:sepimostat
    n1=en:dexecadotril | n2=en:sepimostat | rel=r_associated | relid=0 | w=35
  7. en:flurofamide --- r_associated #0: 35 --> en:sepimostat
    n1=en:flurofamide | n2=en:sepimostat | rel=r_associated | relid=0 | w=35
  8. en:racecadotril --- r_associated #0: 35 --> en:sepimostat
    n1=en:racecadotril | n2=en:sepimostat | rel=r_associated | relid=0 | w=35
  9. en:ecadotril --- r_associated #0: 34 --> en:sepimostat
    n1=en:ecadotril | n2=en:sepimostat | rel=r_associated | relid=0 | w=34
  10. en:fasidotril --- r_associated #0: 34 --> en:sepimostat
    n1=en:fasidotril | n2=en:sepimostat | rel=r_associated | relid=0 | w=34
  11. en:hiv protease inhibitor --- r_associated #0: 34 --> en:sepimostat
    n1=en:hiv protease inhibitor | n2=en:sepimostat | rel=r_associated | relid=0 | w=34
  12. en:semagacestat --- r_associated #0: 34 --> en:sepimostat
    n1=en:semagacestat | n2=en:sepimostat | rel=r_associated | relid=0 | w=34
  13. en:amprenavir --- r_associated #0: 33 --> en:sepimostat
    n1=en:amprenavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=33
  14. en:avagacestat --- r_associated #0: 32 --> en:sepimostat
    n1=en:avagacestat | n2=en:sepimostat | rel=r_associated | relid=0 | w=32
  15. en:begacestat --- r_associated #0: 32 --> en:sepimostat
    n1=en:begacestat | n2=en:sepimostat | rel=r_associated | relid=0 | w=32
  16. en:gemopatrilat --- r_associated #0: 32 --> en:sepimostat
    n1=en:gemopatrilat | n2=en:sepimostat | rel=r_associated | relid=0 | w=32
  17. en:alvelestat --- r_associated #0: 31 --> en:sepimostat
    n1=en:alvelestat | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  18. en:c1 esterase inhibitor (recombinant) --- r_associated #0: 31 --> en:sepimostat
    n1=en:c1 esterase inhibitor (recombinant) | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  19. en:camostat --- r_associated #0: 31 --> en:sepimostat
    n1=en:camostat | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  20. en:candoxatrilat --- r_associated #0: 31 --> en:sepimostat
    n1=en:candoxatrilat | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  21. en:chymotrypsin inhibitor --- r_associated #0: 31 --> en:sepimostat
    n1=en:chymotrypsin inhibitor | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  22. en:cystamine dihydrochloride --- r_associated #0: 31 --> en:sepimostat
    n1=en:cystamine dihydrochloride | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  23. en:freselestat --- r_associated #0: 31 --> en:sepimostat
    n1=en:freselestat | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  24. en:o-chloroacetylcarbamoylfumagillol --- r_associated #0: 31 --> en:sepimostat
    n1=en:o-chloroacetylcarbamoylfumagillol | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  25. en:patamostat --- r_associated #0: 31 --> en:sepimostat
    n1=en:patamostat | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  26. en:proteasome inhibitor --- r_associated #0: 31 --> en:sepimostat
    n1=en:proteasome inhibitor | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  27. en:relacatib --- r_associated #0: 31 --> en:sepimostat
    n1=en:relacatib | n2=en:sepimostat | rel=r_associated | relid=0 | w=31
  28. en:pepstatin --- r_associated #0: 30 --> en:sepimostat
    n1=en:pepstatin | n2=en:sepimostat | rel=r_associated | relid=0 | w=30
  29. en:aderbasib --- r_associated #0: 29 --> en:sepimostat
    n1=en:aderbasib | n2=en:sepimostat | rel=r_associated | relid=0 | w=29
  30. en:camostat mesylate --- r_associated #0: 29 --> en:sepimostat
    n1=en:camostat mesylate | n2=en:sepimostat | rel=r_associated | relid=0 | w=29
  31. en:batebulast --- r_associated #0: 28 --> en:sepimostat
    n1=en:batebulast | n2=en:sepimostat | rel=r_associated | relid=0 | w=28
  32. en:lodelaben --- r_associated #0: 28 --> en:sepimostat
    n1=en:lodelaben | n2=en:sepimostat | rel=r_associated | relid=0 | w=28
  33. en:sivelestat --- r_associated #0: 28 --> en:sepimostat
    n1=en:sivelestat | n2=en:sepimostat | rel=r_associated | relid=0 | w=28
  34. en:aloxistatin --- r_associated #0: 27 --> en:sepimostat
    n1=en:aloxistatin | n2=en:sepimostat | rel=r_associated | relid=0 | w=27
  35. en:depelestat --- r_associated #0: 27 --> en:sepimostat
    n1=en:depelestat | n2=en:sepimostat | rel=r_associated | relid=0 | w=27
  36. en:acluracil --- r_associated #0: 26 --> en:sepimostat
    n1=en:acluracil | n2=en:sepimostat | rel=r_associated | relid=0 | w=26
  37. en:aleplasinin --- r_associated #0: 26 --> en:sepimostat
    n1=en:aleplasinin | n2=en:sepimostat | rel=r_associated | relid=0 | w=26
  38. en:daglutril --- r_associated #0: 26 --> en:sepimostat
    n1=en:daglutril | n2=en:sepimostat | rel=r_associated | relid=0 | w=26
  39. en:efegatran --- r_associated #0: 26 --> en:sepimostat
    n1=en:efegatran | n2=en:sepimostat | rel=r_associated | relid=0 | w=26
  40. en:sivelestat sodium --- r_associated #0: 26 --> en:sepimostat
    n1=en:sivelestat sodium | n2=en:sepimostat | rel=r_associated | relid=0 | w=26
  41. en:angiotensin-converting enzyme inhibitors --- r_associated #0: 20 --> en:sepimostat
    n1=en:angiotensin-converting enzyme inhibitors | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  42. en:aprotinin --- r_associated #0: 20 --> en:sepimostat
    n1=en:aprotinin | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  43. en:asunaprevir --- r_associated #0: 20 --> en:sepimostat
    n1=en:asunaprevir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  44. en:bowman-birk inhibitor concentrate --- r_associated #0: 20 --> en:sepimostat
    n1=en:bowman-birk inhibitor concentrate | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  45. en:cilastatin --- r_associated #0: 20 --> en:sepimostat
    n1=en:cilastatin | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  46. en:cilastatin sodium --- r_associated #0: 20 --> en:sepimostat
    n1=en:cilastatin sodium | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  47. en:ciluprevir --- r_associated #0: 20 --> en:sepimostat
    n1=en:ciluprevir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  48. en:cystamine --- r_associated #0: 20 --> en:sepimostat
    n1=en:cystamine | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  49. en:cysteine proteinase inhibitors --- r_associated #0: 20 --> en:sepimostat
    n1=en:cysteine proteinase inhibitors | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  50. en:darunavir --- r_associated #0: 20 --> en:sepimostat
    n1=en:darunavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  51. en:darunavir ethanolate --- r_associated #0: 20 --> en:sepimostat
    n1=en:darunavir ethanolate | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  52. en:dipeptidyl-peptidase iv inhibitors --- r_associated #0: 20 --> en:sepimostat
    n1=en:dipeptidyl-peptidase iv inhibitors | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  53. en:ecallantide --- r_associated #0: 20 --> en:sepimostat
    n1=en:ecallantide | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  54. en:elastase inhibitor --- r_associated #0: 20 --> en:sepimostat
    n1=en:elastase inhibitor | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  55. en:fda established names and unique ingredient identifier codes terminology --- r_associated #0: 20 --> en:sepimostat
    n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  56. en:fosamprenavir sodium --- r_associated #0: 20 --> en:sepimostat
    n1=en:fosamprenavir sodium | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  57. en:gabexate --- r_associated #0: 20 --> en:sepimostat
    n1=en:gabexate | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  58. en:hiv protease inhibitors --- r_associated #0: 20 --> en:sepimostat
    n1=en:hiv protease inhibitors | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  59. en:indinavir --- r_associated #0: 20 --> en:sepimostat
    n1=en:indinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  60. en:kni-272 --- r_associated #0: 20 --> en:sepimostat
    n1=en:kni-272 | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  61. en:lexiva --- r_associated #0: 20 --> en:sepimostat
    n1=en:lexiva | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  62. en:lopinavir --- r_associated #0: 20 --> en:sepimostat
    n1=en:lopinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  63. en:matrix metalloproteinase inhibitor --- r_associated #0: 20 --> en:sepimostat
    n1=en:matrix metalloproteinase inhibitor | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  64. en:nafamostat --- r_associated #0: 20 --> en:sepimostat
    n1=en:nafamostat | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  65. en:nafamostat mesylate --- r_associated #0: 20 --> en:sepimostat
    n1=en:nafamostat mesylate | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  66. en:ns5b polymerase inhibitor bms-791325 --- r_associated #0: 20 --> en:sepimostat
    n1=en:ns5b polymerase inhibitor bms-791325 | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  67. en:omapatrilat --- r_associated #0: 20 --> en:sepimostat
    n1=en:omapatrilat | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  68. en:paritaprevir --- r_associated #0: 20 --> en:sepimostat
    n1=en:paritaprevir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  69. en:proteinase inhibitor (substance) --- r_associated #0: 20 --> en:sepimostat
    n1=en:proteinase inhibitor (substance) | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  70. en:remikiren --- r_associated #0: 20 --> en:sepimostat
    n1=en:remikiren | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  71. en:ritonavir --- r_associated #0: 20 --> en:sepimostat
    n1=en:ritonavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  72. en:rupintrivir --- r_associated #0: 20 --> en:sepimostat
    n1=en:rupintrivir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  73. en:saquinavir --- r_associated #0: 20 --> en:sepimostat
    n1=en:saquinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  74. en:serine protease inhibitor wx-671 --- r_associated #0: 20 --> en:sepimostat
    n1=en:serine protease inhibitor wx-671 | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  75. en:serine proteinase inhibitors --- r_associated #0: 20 --> en:sepimostat
    n1=en:serine proteinase inhibitors | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  76. en:simeprevir --- r_associated #0: 20 --> en:sepimostat
    n1=en:simeprevir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  77. en:talabostat --- r_associated #0: 20 --> en:sepimostat
    n1=en:talabostat | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  78. en:talabostat mesylate --- r_associated #0: 20 --> en:sepimostat
    n1=en:talabostat mesylate | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  79. en:telaprevir --- r_associated #0: 20 --> en:sepimostat
    n1=en:telaprevir | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  80. en:tissue inhibitor of metalloproteinases --- r_associated #0: 20 --> en:sepimostat
    n1=en:tissue inhibitor of metalloproteinases | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  81. en:tosedostat --- r_associated #0: 20 --> en:sepimostat
    n1=en:tosedostat | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  82. en:trypsin inhibitors --- r_associated #0: 20 --> en:sepimostat
    n1=en:trypsin inhibitors | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  83. en:urinastatin --- r_associated #0: 20 --> en:sepimostat
    n1=en:urinastatin | n2=en:sepimostat | rel=r_associated | relid=0 | w=20
  84. Nélaton (ligne de) --- r_associated #0: 10 --> en:sepimostat
    n1=Nélaton (ligne de) | n2=en:sepimostat | rel=r_associated | relid=0 | w=10
  85. aprotinine --- r_associated #0: 10 --> en:sepimostat
    n1=aprotinine | n2=en:sepimostat | rel=r_associated | relid=0 | w=10
  86. cilastatine --- r_associated #0: 10 --> en:sepimostat
    n1=cilastatine | n2=en:sepimostat | rel=r_associated | relid=0 | w=10
  87. indinavir --- r_associated #0: 10 --> en:sepimostat
    n1=indinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=10
  88. lopinavir --- r_associated #0: 10 --> en:sepimostat
    n1=lopinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=10
  89. ritonavir --- r_associated #0: 10 --> en:sepimostat
    n1=ritonavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=10
  90. saquinavir --- r_associated #0: 10 --> en:sepimostat
    n1=saquinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=10
  91. Nelfinavir --- r_associated #0: 5 --> en:sepimostat
    n1=Nelfinavir | n2=en:sepimostat | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr